4//SEC Filing
D'Alonzo Thomas 4
Accession 0000899243-17-020521
CIK 0001103021other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 6:04 PM ET
Size
11.3 KB
Accession
0000899243-17-020521
Insider Transaction Report
Form 4
D'Alonzo Thomas
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2017-08-14−15,000→ 15,000 totalExercise: $0.00From: 2017-08-14→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2017-08-14+15,000→ 161,379 total - Exercise/Conversion
Common Stock
2017-08-14+15,000→ 146,379 total - Exercise/Conversion
Restricted Stock Units
2017-08-14−15,000→ 0 totalExercise: $0.00From: 2017-08-14Exp: 2017-08-14→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Restricted Stock Units ("RSUs") granted to the Reporting Person on June 30, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended.
- [F2]The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on July 14, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest in the first open window following the Company's 2018 Annual Meeting of Stockholders.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001382542
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 6:04 PM ET
- Size
- 11.3 KB